Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorORIOLO, Giovanni
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorHUET, Lison
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorDEXPERT, Sandra
dc.contributor.authorBEAU, Cedric
dc.contributor.authorFORESTIER, Damien
dc.contributor.authorLEDAGUENEL, Patrick
dc.contributor.authorMAGNE, Eric
dc.contributor.authorMARTIN-SANTOS, Rocio
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorCAPURON, Lucile
IDREF: 167018736
dc.date.accessioned2021-09-01T14:54:23Z
dc.date.available2021-09-01T14:54:23Z
dc.date.issued2019
dc.identifier.issn1090-2139en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/112043
dc.description.abstractEnObesity is a major public health burden associated with neuropsychiatric comorbidities leading to social and occupational impairment. Given the growing prevalence of both obesity and mental disorders worldwide, understanding the risk factors of obesity-related neuropsychiatric comorbidities is crucial to develop preventive strategies and individualized treatments. Recent findings suggest that adiposity-driven inflammation contributes to neuropsychiatric comorbidities in obesity. However, not all obese subjects afflicted with chronic inflammation develop neuropsychiatric symptoms, suggesting additional risk factors. The aim of this study was to investigate the impact of personal history of major depressive disorder (MDD) on obesity-related inflammation and neuropsychiatric symptoms, and their relationship. A case-control study was conducted comparing 66 obese patients (body mass index > 35 kg/m2) and 22 healthy non-obese participants, free of any current neuropsychiatric diseases including MDD. Neuropsychiatric symptoms were assessed using the Neurotoxicity Rating Scale (NRS). Sociodemographic and clinical variables were gathered and blood was collected for the measurement of serum levels of high-sensitivity C-reactive protein (hs-CRP). Multiple regression analyses were performed to assess the contribution of obesity and personal history of MDD to clinical outcomes and inflammatory status in study participants. Hs-CRP levels as well as NRS scores were significantly increased in the obese group. Overall, personal history of depression accounted for increased NRS scores but no significant association was found with inflammatory status. In addition, history of depression did not significantly modulate the relationship of obesity-related inflammation with NRS scores. Interestingly, obese individuals with history of recurrent MDD (n = 13) exhibited higher scores in the cognitive and sickness symptoms dimensions of the NRS compared to obese subjects with history of one depressive episode only. Findings indicate that history of depression contributes to neuropsychiatric symptoms, but not to systemic inflammation, in obese subjects free of current depressive episode. These results provide relevant information on the risk factors that may help identify obese subjects with increased risk of neuropsychiatric comorbidity.
dc.description.sponsorshipRôle de l'Inflammation dans la Symptomatologie Neuropsychiatrique chez le Sujet Obèse - ANR-11-JSV1-0006en_US
dc.language.isoENen_US
dc.subject.enAdult
dc.subject.enBody Mass Index
dc.subject.enC-reactive protein
dc.subject.enC-Reactive Protein
dc.subject.enCase-Control Studies
dc.subject.enComorbidity
dc.subject.enCross-Sectional Studies
dc.subject.enDepression
dc.subject.enDepressive Disorder
dc.subject.enMajor
dc.subject.enFemale
dc.subject.enFrance
dc.subject.enHumans
dc.subject.enInflammation
dc.subject.enMajor depressive disorder (MDD)
dc.subject.enMale
dc.subject.enMental Disorders
dc.subject.enMiddle Aged
dc.subject.enNeuropsychiatric symptoms
dc.subject.enObesity
dc.subject.enPrevalence
dc.subject.enRisk Factors
dc.subject.enVulnerability
dc.title.enHistory of major depression is associated with neuropsychiatric symptoms but not systemic inflammation in a cross-sectional study in obese patients
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.bbi.2018.11.312en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed30476563en_US
bordeaux.journalBrain, Behavior, and Immunityen_US
bordeaux.page215-222en_US
bordeaux.volume76en_US
bordeaux.hal.laboratoriesNutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.teamPsychoneuroimmunologie et Nutrition: Approches expérimentales et cliniquesen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDInstitut National de la Recherche Agronomiqueen_US
bordeaux.identifier.funderIDAgence Nationale de la Rechercheen_US
bordeaux.identifier.funderIDFondation pour la Recherche Médicaleen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Brain,%20Behavior,%20and%20Immunity&rft.date=2019&rft.volume=76&rft.spage=215-222&rft.epage=215-222&rft.eissn=1090-2139&rft.issn=1090-2139&rft.au=ORIOLO,%20Giovanni&HUET,%20Lison&DEXPERT,%20Sandra&BEAU,%20Cedric&FORESTIER,%20Damien&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée